PGNY vs DOCS
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 12, 2026
PGNY
DOCS
Investment Advisor Scores
DOCS
AI Analyst Insights
Detailed Metrics Comparison
| Metric | PGNY | DOCS | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 15.1057 | 24.4499 | PGNY |
| PEG Ratio | 0 | 0.5895 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 8.9% | 3.6% | PGNY |
| Earnings Growth | 113.3% | -41.9% | PGNY |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 31.7/100 | 40.2/100 | DOCS |
| Profit Margin | 6.8% | 21.1% | DOCS |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | EXTENDED | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
PGNY
MarkupPrice above SMA50, rising 50-day trend (7.7% over 20 days), RSI 79
DOCS
MarkupPrice above SMA50, rising 50-day trend (11.0% over 20 days), RSI 59
Fundamentals Snapshot
| Metric | PGNY | DOCS |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 15.1 | 20.6 |
| Trailing P/E | 33.6 | 46.1 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.0% |
| Gross Margin | 0.2% | 0.9% |
| Operating Margin | 0.1% | 0.3% |
| EPS | 1.09 | 0.72 |
| Dividend Yield | — | — |